204 related articles for article (PubMed ID: 34798819)
1. Outcomes between prediabetes and type 2 diabetes mellitus in older adults with acute myocardial infarction in the era of newer-generation drug-eluting stents: a retrospective observational study.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Park SH; Kim BG; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
BMC Geriatr; 2021 Nov; 21(1):653. PubMed ID: 34798819
[TBL] [Abstract][Full Text] [Related]
2. Comparative effect of statin intensity between prediabetes and type 2 diabetes mellitus after implanting newer-generation drug-eluting stents in Korean acute myocardial infarction patients: a retrospective observational study.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
BMC Cardiovasc Disord; 2021 Aug; 21(1):386. PubMed ID: 34372778
[TBL] [Abstract][Full Text] [Related]
3. Prediabetes versus type 2 diabetes mellitus based on pre-percutaneous coronary intervention thrombolysis in myocardial infarction flow grade in patients with ST-segment elevation myocardial infarction after successful newer-generation drug-eluting stent implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Diab Vasc Dis Res; 2021; 18(1):1479164121991505. PubMed ID: 33535819
[TBL] [Abstract][Full Text] [Related]
4. Prediabetes versus type 2 diabetes in patients with acute myocardial infarction and current smoking.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Am J Med Sci; 2022 Nov; 364(5):612-623. PubMed ID: 35595078
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two-year clinical outcomes according to glycemic status and renal function in patients with acute myocardial infarction following implantation of new-generation drug-eluting stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
J Diabetes Complications; 2021 Nov; 35(11):108019. PubMed ID: 34400082
[TBL] [Abstract][Full Text] [Related]
6. Effect of statin treatment in patients with acute myocardial infarction with prediabetes and type 2 diabetes mellitus: A retrospective observational registry study.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Medicine (Baltimore); 2021 Feb; 100(6):e24733. PubMed ID: 33578620
[TBL] [Abstract][Full Text] [Related]
7. Effects of Hypertension on Two-Year Outcomes According to Glycemic Status in Patients With Acute Myocardial Infarction Receiving Newer-Generation Drug-Eluting Stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Park SH; Kim S; Kim BG; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Angiology; 2023 Mar; 74(3):227-241. PubMed ID: 35537217
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Durable-Polymer- and Biodegradable-Polymer-Based Newer-Generation Drug-Eluting Stents in Patients with Acute Myocardial Infarction and Prediabetes After Successful Percutaneous Coronary Intervention.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Int Heart J; 2020 Jul; 61(4):673-684. PubMed ID: 32684595
[TBL] [Abstract][Full Text] [Related]
9. Two-Year Clinical Outcomes Between Prediabetic and Diabetic Patients With STEMI and Multivessel Disease Who Underwent Successful PCI Using Drug-Eluting Stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Angiology; 2021 Jan; 72(1):50-61. PubMed ID: 32806925
[TBL] [Abstract][Full Text] [Related]
10. Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Sci Rep; 2021 Apr; 11(1):9364. PubMed ID: 33931673
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme inhibitors versus angiotensin II type 1 receptor blockers in patients with acute myocardial infarction and prediabetes after successful implantation of newer-generation drug-eluting stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Park SH; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Cardiol J; 2023; 30(4):614-626. PubMed ID: 34622435
[TBL] [Abstract][Full Text] [Related]
12. Effect of renin-angiotensin system inhibitors on major clinical outcomes in patients with acute myocardial infarction and prediabetes or diabetes after successful implantation of newer-generation drug-eluting stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
J Diabetes Complications; 2020 Jun; 34(6):107574. PubMed ID: 32147394
[TBL] [Abstract][Full Text] [Related]
13. Effects of prediabetes on long-term clinical outcomes of patients with acute myocardial infarction who underwent PCI using new-generation drug-eluting stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Diabetes Res Clin Pract; 2020 Feb; 160():107994. PubMed ID: 31881240
[TBL] [Abstract][Full Text] [Related]
14. Comparison of First- and Second-Generation Drug-Eluting Stents in Patients with Acute Myocardial Infarction and Prediabetes Based on the Hemoglobin A1c Level.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
J Interv Cardiol; 2020; 2020():1710439. PubMed ID: 32733169
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in prediabetes vs. diabetes in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous intervention.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Coron Artery Dis; 2021 May; 32(3):211-223. PubMed ID: 33060525
[TBL] [Abstract][Full Text] [Related]
16. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
[TBL] [Abstract][Full Text] [Related]
17. Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute Myocardial Infarction Registry.
Kim YH; Her AY; Jeong MH; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2019 Jun; 93(7):1264-1275. PubMed ID: 30474346
[TBL] [Abstract][Full Text] [Related]
18. Beta-Blocker and Renin-Angiotensin System Inhibitor Combination Therapy in Patients with Acute Myocardial Infarction and Prediabetes or Diabetes Who Underwent Successful Implantation of Newer-Generation Drug-Eluting Stents: A Retrospective Observational Registry Study.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33120966
[TBL] [Abstract][Full Text] [Related]
19. Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
Ploumen EH; Buiten RA; Kok MM; Doggen CJM; van Houwelingen KG; Stoel MG; de Man FHAF; Hartmann M; Zocca P; Linssen GCM; Doelman C; Kant GD; von Birgelen C
Catheter Cardiovasc Interv; 2020 Aug; 96(2):E110-E118. PubMed ID: 31625262
[TBL] [Abstract][Full Text] [Related]
20. Impacts of renin-angiotensin system inhibitors on two-year clinical outcomes in diabetic and dyslipidemic acute myocardial infarction patients after a successful percutaneous coronary intervention using newer-generation drug-eluting stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Medicine (Baltimore); 2020 Jul; 99(30):e21289. PubMed ID: 32791710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
